First Horizon Advisors Inc. lowered its holdings in Edwards Lifesciences Co. (NYSE:EW – Free Report) by 2.3% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 99,339 shares of the medical research company’s stock after selling 2,343 shares during the quarter. First Horizon Advisors Inc.’s […]